🇺🇸 FDA
Patent

US 9872909

Method for enhancing specific immunotherapies in cancer treatment

granted A61KA61K2039/505A61K39/39558

Quick answer

US patent 9872909 (Method for enhancing specific immunotherapies in cancer treatment) held by Providence Health & Services—Oregon expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Providence Health & Services—Oregon
Grant date
Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K39/39558, A61K47/26, A61K9/0019